Literature DB >> 29871019

Bacterial Infections in Acute-on-Chronic Liver Failure.

Lingling Yang1, Tianzhou Wu1,2, Jiang Li1, Jun Li1.   

Abstract

Acute-on-chronic liver failure (ACLF) is a newly recognized clinical syndrome characterized by preexisting chronic liver disease or cirrhosis with organ failure and high 28-day mortality (50-90%). Bacterial infections (BIs) play pivotal roles in the development and progression of ACLF either as a main precipitating event or a specific complication. The main organisms isolated as triggering ACLF are Gram-positive bacteria, followed by Gram-negative bacteria. Spontaneous bacterial peritonitis, pneumonia, urinary tract infections, and skin infections are prevalent infections that trigger and complicate ACLF. Despite appropriate antibiotic treatment, BIs account for poor ACLF outcomes and lead to a worse clinical course and higher intensive care unit admission and short-term mortality. Early diagnosis and novel nonantibiotic methods are highly important for managing BIs. Thus, this review focuses on the epidemiology, prognosis, and diagnosis of and management strategies for BIs in ACLF patients as well as the relationship between BIs and ACLF. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29871019     DOI: 10.1055/s-0038-1657751

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  8 in total

1.  Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice.

Authors:  Xiaogang Xiang; Dechun Feng; Seonghwan Hwang; Tianyi Ren; Xiaolin Wang; Eszter Trojnar; Csaba Matyas; Ruidong Mo; Dabao Shang; Yong He; Wonhyo Seo; Vijay H Shah; Pal Pacher; Qing Xie; Bin Gao
Journal:  J Hepatol       Date:  2019-11-29       Impact factor: 25.083

Review 2.  Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes.

Authors:  Giuseppe Cullaro; Rajani Sharma; Jonel Trebicka; Andrés Cárdenas; Elizabeth C Verna
Journal:  Liver Transpl       Date:  2020-01-06       Impact factor: 5.799

3.  Risk factors and prognostic model for HBV-related subacute liver failure.

Authors:  Juan Xu; Fenjing Du; Nan Yang; Jingtao Hou; Yan Fan; Xiaojing Liu
Journal:  Ann Transl Med       Date:  2022-04

4.  Acute-on-Chronic Liver Failure: From Basic Research to Clinical Applications.

Authors:  En-Qiang Chen; Tetsuro Shimakami; Yu-Chen Fan; Paolo Angeli
Journal:  Can J Gastroenterol Hepatol       Date:  2018-10-08

5.  Sites and Causes of Infection in Patients with Sepsis-Associated Liver Dysfunction: A Population Study from the Medical Information Mart for Intensive Care III.

Authors:  Jinfeng Lin; Chunfeng Gu; Suyan Zhang; Lijun Tian; Ke Ren; Zhilong Cao; Xudong Han
Journal:  Med Sci Monit       Date:  2021-02-27

Review 6.  Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management.

Authors:  Arshi Khanam; Shyam Kottilil
Journal:  Front Med (Lausanne)       Date:  2021-11-08

7.  Role of Bacterial Infection in the Development of Acute Liver Failure in Patients with Decompensated Alcoholic Liver Cirrhosis.

Authors:  A S Rodina; M E Shubina; I V Kurbatova; O P Dudanova
Journal:  Bull Exp Biol Med       Date:  2021-07-23       Impact factor: 0.804

Review 8.  Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics.

Authors:  Arshi Khanam; Shyam Kottilil
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.